Assessing the efficacy of the Stop OsteoARthritis (SOAR) program: A randomized delayed-controlled trial in persons at increased risk of early onset post-traumatic knee osteoarthritis
Osteoarthritis and Cartilage · 2024-08 · 32 (8) · 1001-1012
DOI: 10.1016/j.joca.2024.04.003 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Osteoarthritis and Cartilage, 2024-08. Verfasst von Justin M Losciale und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Therapy, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Arthritis Research Canada, …. Hauptthemen laut MEDLINE: Osteoarthritis, Knee, Exercise Therapy, Knee Injuries. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Michael Smith Foundation for Health Research, Canadian Institutes of Health Research, Arthritis Society Canada.
Abstract (Originalsprache)
OBJECTIVE: Assess the efficacy of an 8-week virtual, physiotherapist (PT)-guided knee health program (Stop OsteoARthritis (SOAR)) to improve knee extensor strength in individuals at risk of post-traumatic knee osteoarthritis (PTOA). METHOD: In this superiority, randomized delayed-control trial, persons aged 16-35 years, 1-4 years after a self-reported knee joint injury were randomly assigned (1:1) to receive the SOAR program immediately (experimental group) or after a 9-week delay (control group). SOAR includes 1) one-time Knee Camp (virtual PT-guided group education, knee assessment, 1:1 exercise and physical activity (PA) goal-setting); 2) Weekly personalized home-based exercise and PA program with tracking; 3) Weekly 1:1 PT counseling (virtual). The primary outcome was a change in isokinetic knee extensor strength (baseline to 9-weeks). Additional outcomes included change in self-reported knee-related quality-of-life (QOL), self-efficacy, self-management and kinesiophobia, and PA (accelerometer) at 9 and 18-weeks. Linear regression models estimated the effect of the 8-week intervention at the primary endpoint (9-week). RESULTS: 49 of 54 randomized participants completed the study (91%). Participants were a mean ± standard deviation age of 27 ± 5.0 years, and 2.4 ± 0.9 years post-injury. No mean between group differences for the primary (0.05; 95% confidence interval (CI): -0.10, 0.19) or other outcomes were seen at 9 weeks except for greater improvements in perceived self-management (Partner in Health Scale; 11.3/96, 95%CI: 5.5, 17.1) and kinesiophobia (Tampa Scale of Kinesiophobia; -4.4/33, 95%CI: -7.0, -1.8). CONCLUSION: For active persons with elevated risk of PTOA, an 8-week SOAR program did not change knee-related strength, QOL, self-efficacy, or PA, on average, but may benefit the ability to self-manage knee health and kinesiophobia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physical Therapy, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Arthritis Research Canada, Vancouver, British Columbia, Canada.
- British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
- Arthritis Research Canada, Vancouver, British Columbia, Canada.
- Faculty of Rehabilitation Medicine, University of Alberta, Edmonton, Alberta, Canada.
- Glen Sather Sports Medicine Clinic, University of Alberta, Edmonton, Alberta, Canada.
- Arthritis Research Canada, Vancouver, British Columbia, Canada; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
Förderung
- Michael Smith Foundation for Health Research
- Canadian Institutes of Health Research
- Arthritis Society Canada
Zitieren
APA
Losciale, J. M., Truong, L. K., Zhang, K., Silvester-Lee, T., Miciak, M., Pajkic, A., Le, C. Y., Xie, H., Hoens, A. M., Mosewich, A. D., Hunt, M. A., Li, L. C., Roos, E. M., & Whittaker, J. L. (2024). Assessing the efficacy of the Stop OsteoARthritis (SOAR) program: A randomized delayed-controlled trial in persons at increased risk of early onset post-traumatic knee osteoarthritis. Osteoarthritis and Cartilage, 32(8), 1001-1012. https://doi.org/10.1016/j.joca.2024.04.003
Vancouver
Losciale JM, Truong LK, Zhang K, Silvester-Lee T, Miciak M, Pajkic A, et al. Assessing the efficacy of the Stop OsteoARthritis (SOAR) program: A randomized delayed-controlled trial in persons at increased risk of early onset post-traumatic knee osteoarthritis. Osteoarthritis and Cartilage. 2024;32(8):1001-1012. doi:10.1016/j.joca.2024.04.003
BibTeX
@article{Losciale2024,
author = {Losciale, Justin M and Truong, Linda K and Zhang, Kexin and Silvester-Lee, Trish and Miciak, Maxi and Pajkic, Andrea and Le, Christina Y and Xie, Hui and Hoens, Alison M and Mosewich, Amber D and Hunt, Michael A and Li, Linda C and Roos, Ewa M and Whittaker, Jackie L},
title = {Assessing the efficacy of the Stop OsteoARthritis (SOAR) program: A randomized delayed-controlled trial in persons at increased risk of early onset post-traumatic knee osteoarthritis},
journal = {Osteoarthritis and Cartilage},
year = {2024},
volume = {32},
number = {8},
pages = {1001--1012},
doi = {10.1016/j.joca.2024.04.003}
}
EUVIMED